Chronic PainNCT02658474
Multidisciplinary Group Based Treatment of Patients With Chronic Pain
A study testing Acceptance and Commitment Therapy in people with Chronic Pain, run by University of Tromso at 1 site in Norway.
Trial summary
The purpose of this study is to determine whether group based Acceptance and Commitment Therapy (ACT) at a university hospital clinic is superior to treatment in a primary care setting among patients with chronic pain. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Pain
- What is being tested?
- Acceptance and Commitment Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 122 participants
- Where
- 1 siteNorway
- Study dates
- Aug 2016to 2 Oct 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Long-term pain condition over 6 months.
- Strongest pain ≥ 4 on a scale of 0 to 10.
- Consent competent and over 18 years
- Motivated for group-based psychological (ACT) treatment.
Who cannot join
- Psychiatric illness and behavioral problems, including substance abuse that prevents good group interaction
- Severe progressive disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Multidisciplinary Group Based Treatment of Patients With Chronic Pain. A Randomized Controlled Trial Comparing Acceptance Commitment Therapy and Treatment in a Primary Care Setting
The purpose of this study is to determine whether group based Acceptance and Commitment Therapy (ACT) at a university hospital clinic is superior to treatment in a primary care setting among patients with chronic pain.
Hypothesis:
- A group based ACT treatment leads to less pain and greater Health Related Quality of Life (HRQOL) in patients with chronic pain than treatment in a primary care setting. ii) The improvement in pain and HRQOL is mediated through an increased degree of pain willingness and involvement in activities. iii) Improvement of pain and HRQOL after the two treatments is associated with demographic, psychosocial and somatic characteristics.
Read the detailed description
Background:
Chronic pain represents a substantial social problem. In Norway, the prevalence of chronic moderate pain is between 25 and 30%, and for severe pain it is at 2%. Multidisciplinary treatment is recommended for chronic pain, and during the last years Acceptance Commitment Therapy (ACT) has been implemented.
Research design, methods and analyses:
One hundred and twenty participants will be recruited from a list of patients referred to the Multidisciplinary Pain Department at the University Hospital of North Norway. Those who meet the defined criteria, are invited to participate. The study has a randomized, semi-crossover design. The participants are allocated to group based ACT or treatment in a primary care setting with a gender stratified, block randomization with a ratio of 1: 1. This means that half of the participants (intervention group, n: 60) get early group based ACT, while the other half (control group, n: 60) will be treated in a primary health care setting. Those of the control group who still meet the criteria, will be offered ACT afterwards.
Data collection will take place at a) start of the study, b) a few days prior to the onset of ACT and c) a few days after ended ACT, and 6 months after the onset of ACT. Data collection is carried out with the same time intervals in the control group. After having received ACT data is collected 12 months after the onset of ACT.
Treatment protocol:
At the first appointment all participants undergo a multidisciplinary evaluation where participants alternate between telling their life story and listening to responses from the multidisciplinary team. The aim is to initiate a reflexive attitude and a feeling of being acknowledged. The multidisciplinary report to the general practitioner provides diagnostic considerations as well as recommendations for future treatment.
- Intervention group: Acceptance Commitment Therapy (ACT) is based on the principles of operant conditioning and is less problem-oriented compared with Cognitive Behavioral Therapy (CBT). The patients learn how to accept and to realize that thoughts, feelings and sensations do not have to decide how life is. In a comparative efficacy study ACT has been shown equally effective as CBT.
Mindfulness Based Stress Reduction is included in ACT, and the patients will therefore get a systematic training in mastering stress and emotional conflicts.
B: Control Group: Patients in the control group are primarily treated by the general practitioner supported by recommendations from the multidisciplinary pain team. The treatment will vary in content and form.
Variables:
Electronic data storage: Data will be collected by an internet based system according the the Norwegian regulations for social insurance and are imported and stored anonymized in a password protected SPSS file data at the University Hospital of North Norway.
Variables:
The demographic variables include gender, year of birth, marital status, number of children, education, occupation and employment status, as well as benefits from the social security system (NAV), financial situation and possible compensation or application for disability.
Clinical variables include comorbidity specified by a list of diseases related to the major organ systems.
Pain analyses: Pain intensity is one of two primary outcomes and is measured with four numerical scales for pain intensity (0 being no pain and 10 the worst possible pain) obtained from the Brief Pain Inventory. Localization (specified by a body map) and temporal aspects, duration and variety of pain are also measured
Health related Quality of life: Short form 36 (version 2).
Physical activity: The Gothenburg Activity Question .
Sleep: Insomnia Severity Index is a self-reporting questionnaire that assesses the severity of the sleeping problems. The form contains seven questions answered with a 5 point Likert scale.
Fatigue: Chalder fatigue questionnaire contains 11 questions and operates with 4 answer options with varying degrees of severity.
Anxiety and depression: Hopkins Symptom Checklist 25 with 25 questions about anxiety and depression.
Pain catastrophizing: The Pain Catastrophizing Scale with 13 questions measuring rumination, worst case thinking and helplessness. General Self-Efficacy: General Perceived Self-Efficacy Questionnaire is based on Bandura's model.
Adverse life events: Those who report positively on a severe life event are asked to fill in Impact of Event Scale-6 with 6 questions related to thoughts after traumatic life event.
Specific evaluation of the ACT intervention: The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) includes 20 items selected to assess the degree of pain willingness and involvement in relation to activities.
Use of health services: Type and number of treatments given in and outside the Pain department with waiting time and expectations to treatment.
Drug Consumption: Consumption of non-opioids (paracetamol and NSAIDs), opioids (daily dose is converted to morphine equivalents), and coanalgesics (antidepressants and anticonvulsants) are recorded by a physician.
Statistics: The investigators will perform repeated comparisons of the two treatment groups over a 6 month period, and "within-group" comparisons of ACT treated patients over a 12 month period. The statistical analyses will be carried out in collaboration with a statistician. Comparison analyses between the groups and to baseline as well as predictor analyses will be performed by Mixed models (SPSS).
Power: Based on previously published studies and power calculations from pilot data, a statistical power of 80% and significance level of 5% the investigators will include 120 patients.
Project plan, project, organization and Cooperation:
The project is an independent part in a national multicenter survey of patients treated at multidisciplinary pain departments at university hospitals in Norway. Our project will largely use the same screening measures and outcomes as the national survey.
Ethics: This study compares two established therapy modalities offered to patients referred to the Pain department at the University Hospital of North Norway. The project was approved by the Regional Committee for Medical and Health research ethics 10/12/13.
- Conditions
- Chronic Pain
- Being tested
- Acceptance and Commitment Therapy
- Keywords
- Chronic pain, Acceptance and Commitment Therapy, Multidisciplinary treatment, Group treatment
- Medical subject headings
- Chronic Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Acceptance and Commitment TherapyBehavioural
Group based Acceptance and Commitment Therapy
| Study group | Role | What they receive |
|---|---|---|
| ACT-group | Experimental | Group based Acceptance and Commitment Therapy. The patients will attend to three sessions which last for three days. Between the sessions the patients will train at home on ACT related topics. The whole intervention will last for three months. Receives: Behavioral: Acceptance and Commitment Therapy |
| Primary care | No intervention | Treatment in a primary care setting. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Group difference in pain intensity
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Measured: 3 months after baseline
Group difference in pain intensity
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Measured: 6 months after baseline
Group difference in health related quality of life
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
Measured: 3 months after baseline
Group difference in health related quality of life
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
Measured: 6 months after baseline
Secondary outcomes (11)
Change from baseline in pain intensity
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Measured: 3 months after baseline
Change from baseline in pain intensity
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Measured: 6 months after baseline
Change from baseline in pain intensity
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Measured: 12 months after baseline
Change from baseline in health related quality of life
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
Measured: 3 months after baseline
Change from baseline in health related quality of life
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
Measured: 6 months after baseline
Change from baseline in health related quality of life
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
Measured: 12 months after baseline
Change from baseline in pain willingness and involvement in activities
The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) and analyzed by Mixed Model
Measured: 3 months after baseline
Change from baseline in pain willingness and involvement in activities
The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) and analyzed by Mixed Model
Measured: 6 months after baseline
Change from baseline in pain willingness and involvement in activities
The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) and analyzed by Mixed Model
Measured: 12 months after baseline
Group difference in drug consumption
Number of analgesics and morphine equivalents analyzed by Mixed Model
Measured: 6 months after baseline
Group difference in consumption of health services
Number of health services applied is counted and analyzed by Mixed Model
Measured: 6 months after baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jan 2016 (estimated)
- Study startAug 2016
- Primary completion2 Oct 2021
- Study completion2 Oct 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 122 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Tromso
- Sponsor type
- University, hospital or other
- Collaborators
- The Royal Norwegian Ministry of Health
- Responsible party
- Sponsor
- Investigators
- Gunnvald Kvarstein, PhD, Principal investigator, UiT The Arctic University of Tromsø
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02658474
- Sponsor's protocol ID
- 2013/1880REK
- Status last verified
- May 2025
- First submitted
- 14 Jan 2016
- Last updated
- 13 May 2025
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multidisciplinary Group Based Treatment of Patients With Chronic Pain. A Randomized Controlled Trial Comparing Acceptance Commitment Therapy and Treatment in a Primary Care Setting
- ClinicalTrials.gov ID
- NCT02658474
- Acronym / sponsor ID
- 2013/1880REK
- Conditions
- Chronic Pain
- Keywords
- Chronic pain, Acceptance and Commitment Therapy, Multidisciplinary treatment, Group treatment
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 122 participants (actual)
- Lead sponsor
- University of TromsoUniversity, hospital or other
- Collaborators
- The Royal Norwegian Ministry of Health
- Study start
- Aug 2016
- Primary completion
- 2 Oct 2021 (actual)
- Study completion
- 2 Oct 2021 (actual)
- First posted
- 18 Jan 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether group based Acceptance and Commitment Therapy (ACT) at a university hospital clinic is superior to treatment in a primary care setting among patients with chronic pain.
Hypothesis:
- A group based ACT treatment leads to less pain and greater Health Related Quality of Life (HRQOL) in patients with chronic pain than treatment in a primary care setting. ii) The improvement in pain and HRQOL is mediated through an increased degree of pain willingness and involvement in activities. iii) Improvement of pain and HRQOL after the two treatments is associated with demographic, psychosocial and somatic characteristics.
Detailed description
Background:
Chronic pain represents a substantial social problem. In Norway, the prevalence of chronic moderate pain is between 25 and 30%, and for severe pain it is at 2%. Multidisciplinary treatment is recommended for chronic pain, and during the last years Acceptance Commitment Therapy (ACT) has been implemented.
Research design, methods and analyses:
One hundred and twenty participants will be recruited from a list of patients referred to the Multidisciplinary Pain Department at the University Hospital of North Norway. Those who meet the defined criteria, are invited to participate. The study has a randomized, semi-crossover design. The participants are allocated to group based ACT or treatment in a primary care setting with a gender stratified, block randomization with a ratio of 1: 1. This means that half of the participants (intervention group, n: 60) get early group based ACT, while the other half (control group, n: 60) will be treated in a primary health care setting. Those of the control group who still meet the criteria, will be offered ACT afterwards.
Data collection will take place at a) start of the study, b) a few days prior to the onset of ACT and c) a few days after ended ACT, and 6 months after the onset of ACT. Data collection is carried out with the same time intervals in the control group. After having received ACT data is collected 12 months after the onset of ACT.
Treatment protocol:
At the first appointment all participants undergo a multidisciplinary evaluation where participants alternate between telling their life story and listening to responses from the multidisciplinary team. The aim is to initiate a reflexive attitude and a feeling of being acknowledged. The multidisciplinary report to the general practitioner provides diagnostic considerations as well as recommendations for future treatment.
- Intervention group: Acceptance Commitment Therapy (ACT) is based on the principles of operant conditioning and is less problem-oriented compared with Cognitive Behavioral Therapy (CBT). The patients learn how to accept and to realize that thoughts, feelings and sensations do not have to decide how life is. In a comparative efficacy study ACT has been shown equally effective as CBT.
Mindfulness Based Stress Reduction is included in ACT, and the patients will therefore get a systematic training in mastering stress and emotional conflicts.
B: Control Group: Patients in the control group are primarily treated by the general practitioner supported by recommendations from the multidisciplinary pain team. The treatment will vary in content and form.
Variables:
Electronic data storage: Data will be collected by an internet based system according the the Norwegian regulations for social insurance and are imported and stored anonymized in a password protected SPSS file data at the University Hospital of North Norway.
Variables:
The demographic variables include gender, year of birth, marital status, number of children, education, occupation and employment status, as well as benefits from the social security system (NAV), financial situation and possible compensation or application for disability.
Clinical variables include comorbidity specified by a list of diseases related to the major organ systems.
Pain analyses: Pain intensity is one of two primary outcomes and is measured with four numerical scales for pain intensity (0 being no pain and 10 the worst possible pain) obtained from the Brief Pain Inventory. Localization (specified by a body map) and temporal aspects, duration and variety of pain are also measured
Health related Quality of life: Short form 36 (version 2).
Physical activity: The Gothenburg Activity Question .
Sleep: Insomnia Severity Index is a self-reporting questionnaire that assesses the severity of the sleeping problems. The form contains seven questions answered with a 5 point Likert scale.
Fatigue: Chalder fatigue questionnaire contains 11 questions and operates with 4 answer options with varying degrees of severity.
Anxiety and depression: Hopkins Symptom Checklist 25 with 25 questions about anxiety and depression.
Pain catastrophizing: The Pain Catastrophizing Scale with 13 questions measuring rumination, worst case thinking and helplessness. General Self-Efficacy: General Perceived Self-Efficacy Questionnaire is based on Bandura's model.
Adverse life events: Those who report positively on a severe life event are asked to fill in Impact of Event Scale-6 with 6 questions related to thoughts after traumatic life event.
Specific evaluation of the ACT intervention: The questionnaire Chronic Pain Acceptance Questionnaire (CPAQ 20) includes 20 items selected to assess the degree of pain willingness and involvement in relation to activities.
Use of health services: Type and number of treatments given in and outside the Pain department with waiting time and expectations to treatment.
Drug Consumption: Consumption of non-opioids (paracetamol and NSAIDs), opioids (daily dose is converted to morphine equivalents), and coanalgesics (antidepressants and anticonvulsants) are recorded by a physician.
Statistics: The investigators will perform repeated comparisons of the two treatment groups over a 6 month period, and "within-group" comparisons of ACT treated patients over a 12 month period. The statistical analyses will be carried out in collaboration with a statistician. Comparison analyses between the groups and to baseline as well as predictor analyses will be performed by Mixed models (SPSS).
Power: Based on previously published studies and power calculations from pilot data, a statistical power of 80% and significance level of 5% the investigators will include 120 patients.
Project plan, project, organization and Cooperation:
The project is an independent part in a national multicenter survey of patients treated at multidisciplinary pain departments at university hospitals in Norway. Our project will largely use the same screening measures and outcomes as the national survey.
Ethics: This study compares two established therapy modalities offered to patients referred to the Pain department at the University Hospital of North Norway. The project was approved by the Regional Committee for Medical and Health research ethics 10/12/13.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ACT-group | Experimental | Behavioral: Acceptance and Commitment TherapyGroup based Acceptance and Commitment Therapy. The patients will attend to three sessions which last for three days. Between the sessions the patients will train at home on ACT related topics. The whole intervention will last for three months. |
| Primary care | No intervention | –Treatment in a primary care setting. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Long-term pain condition over 6 months.
- Strongest pain ≥ 4 on a scale of 0 to 10.
- Consent competent and over 18 years
- Motivated for group-based psychological (ACT) treatment.
Key exclusion criteria (2 listed)
- Psychiatric illness and behavioral problems, including substance abuse that prevents good group interaction
- Severe progressive disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Acceptance and Commitment TherapyGroup based Acceptance and Commitment Therapy | Behavioural | ACT-group |
Primary outcome
Group difference in pain intensity
Time frame: 3 months after baseline
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Group difference in pain intensity
Time frame: 6 months after baseline
Continuous variable (Numeric rating scale) analyzed by Mixed Model
Group difference in health related quality of life
Time frame: 3 months after baseline
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
Group difference in health related quality of life
Time frame: 6 months after baseline
Health related quality of life is measured by Short Form-36 and analyzed by Mixed Model
11 secondary outcomes
Change from baseline in pain intensity
Time frame: 3 months after baseline
Change from baseline in pain intensity
Time frame: 6 months after baseline
Change from baseline in pain intensity
Time frame: 12 months after baseline
Change from baseline in health related quality of life
Time frame: 3 months after baseline
Change from baseline in health related quality of life
Time frame: 6 months after baseline
Change from baseline in health related quality of life
Time frame: 12 months after baseline
Change from baseline in pain willingness and involvement in activities
Time frame: 3 months after baseline
Change from baseline in pain willingness and involvement in activities
Time frame: 6 months after baseline
Change from baseline in pain willingness and involvement in activities
Time frame: 12 months after baseline
Group difference in drug consumption
Time frame: 6 months after baseline
Group difference in consumption of health services
Time frame: 6 months after baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2025.
- Individual participant dataSharing planned: No
Related trials for Chronic Pain
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Effect of Lumbar Stabilization Exercises With and Without YTWL (Scapular Stabilization Exercises) on Reducing Chronic Low Back Pain and Related Disability. A Randomized Clinical Trial,
Chronic Non Specific Mechanical Low Back Pain
Not yet recruiting
Comparing Non-Medicine Strategies for Improving Low Back Pain
Chronic Low-back Pain (cLBP), High-Impact Chronic Pain (HICP)
Not yet recruiting
Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain
Breast Cancer, Postoperative Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gunnvald Kvarstein, PhD principal investigator
UiT The Arctic University of Tromsø
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acceptance and Commitment Therapy in people with Chronic Pain, run by University of Tromso at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Group difference in pain intensity (time frame: 3 months after baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2025.